Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Disease, Fungal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04554875
What this trial is testing

Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules

Who this might be right for
CryptococcosisLung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China 1,000
Post-approval studies (Phase 4)UnknownNCT02234739
What this trial is testing

Voriconazole for IPA in Chinese Patients With COPD

Who this might be right for
Invasive Pulmonary AspergillosisCOPD
Red Cross Hospital, Hangzhou, China 40
Not applicableNot Yet RecruitingNCT07230457
What this trial is testing

Plasma MTB cfDNA Before Bronchoscopy

Who this might be right for
Tuberculosis Diagnosis
Chinese University of Hong Kong 600
Large-scale testing (Phase 3)Looking for participantsNCT04310930
What this trial is testing

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Who this might be right for
Pulmonary Disease Due to Mycobacteria (Diagnosis)
The University of Queensland 300
Early research (Phase 1)Study completedNCT03423030
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Innovative Medicines for Tuberculosis 32
Early research (Phase 1)WithdrawnNCT03159975
What this trial is testing

Safety and Immunogenicity Study of GX-70 in TB Patient

Who this might be right for
Pulmonary TuberculosesHigh Risk Factors for RelapseTreatment Failure
Yonsei University
Not applicableStudy completedNCT00341601
What this trial is testing

Multi-Drug Resistant Tuberculosis in Korea

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 777
Testing effectiveness (Phase 2)Study completedNCT00004811
What this trial is testing

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

Who this might be right for
HistoplasmosisSporotrichosisBlastomycosis
National Center for Research Resources (NCRR) 7
Early research (Phase 1)Study completedNCT00001911
What this trial is testing

Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections

Who this might be right for
Atypical Mycobacterium Infection
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00111644
What this trial is testing

Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

Who this might be right for
Pneumonia, Bacterial
Hoffmann-La Roche 302
Not applicableUnknownNCT05982912
What this trial is testing

VOC in Breath Samples for the Diagnosis of IPA

Who this might be right for
Invasive Pulmonary AspergillosisBreath SamplesVolatile Organic Compounds
Rambam Health Care Campus 200
Not applicableStudy completedNCT06136832
What this trial is testing

Pneumonia Vaccine Education Intervention Study

Who this might be right for
Pneumonia, PneumococcalVaccine
Geisinger Clinic 141
Early research (Phase 1)Study completedNCT00000739
What this trial is testing

Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Not applicableLooking for participantsNCT07783971
What this trial is testing

Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance

Who this might be right for
Fungal DiseasesLung Cancer (NSCLC)Microbioata
958th Army Hospital of the Chinese People's Liberation Army 10
Post-approval studies (Phase 4)Looking for participantsNCT06499233
What this trial is testing

Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease

Who this might be right for
Pneumonia, PneumocystisAutoimmune Inflammatory Rheumatic DiseaseAutoimmune Diseases+2 more
Tongji Hospital 800
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Large-scale testing (Phase 3)Study completedNCT00784368
What this trial is testing

A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection

Who this might be right for
MycosesCandidiasisAspergillosis+4 more
Janssen Pharmaceutical K.K. 55
Testing effectiveness (Phase 2)Study completedNCT00021567
What this trial is testing

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections

Who this might be right for
Mycobacterium Avium-Intracellulare Infection
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT04278248
What this trial is testing

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Who this might be right for
Pneumonia, Pneumococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,940
Not applicableStudy completedNCT07055230
What this trial is testing

Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)

Who this might be right for
Allergic Bronchopulmonary Aspergillosis (ABPA)
University Hospital, Rouen 67
Next Page